Back to search
Axial Spondyloarthritis (axSpA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Axial Spondyloarthritis (axSpA) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Axial Spondyloarthritis (axSpA) trials you may qualify forTo demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.
This is a multi-center, double-blind, placebo-controlled, Phase 2, proof-of-concept basket study with the goal of assessing the efficacy and safety of SPY072 co…
Background: \- Spondyloarthritis (SpA) is a group of bone and joint disorders that may cause back and joint pain and stiffness. In some cases, SpA can lead to…
This prospective, multicenter, controlled real-world quality management study explores the acceptance and utility of two measures discussed in the context of th…
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
This study is a multicenter, prospective cohort study designed to systematically evaluate the clinical efficacy of integrated Traditional Chinese and Western Me…
The purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA…
the main objectives are 1. to study the pathophysiological role of KIR3DL2 in axSpA and its relationship with Th17 immunity in HLA-B27 + and HLA-B27- patients…